Tag: Drug Approvals
FDA OKs Vagus Nerve Stimulator to Treat Cluster Headaches
Hand-held, noninvasive device provides new option
FDA Approves First Drug for Treatment of Tardive Dyskinesia
Ingrezza (valbenazine) capsules approved for treatment of adults with tardive dyskinesia
FDA Approves Dupixent to Treat Eczema
Active ingredient binds to protein (interleukin-4 receptor alpha subunit) that causes inflammation
FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis
First drug sanctioned in United States for primary progressive multiple sclerosis
FDA Approves Zejula for Certain Female Cancers
PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum
FDA Approves Bavencio for Merkel Cell Carcinoma
Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States
FDA Approves New Parkinson’s Add-On Drug Xadago
To help prevent 'off' episodes among users of levodopa/carbidopa
FDA Approves Noctiva Nasal Spray for Nocturnal Polyuria
Drug designed to increase absorption of water through the kidneys, decreasing urine production
FDA Approves Odactra for House Dust Mite Allergies
Year-round, once-a-day tablet that's taken sublingually
FDA Approves Xermelo for Carcinoid Syndrome Diarrhea
Oral tablets to be used in combination with somatostatin analog therapy
